IMUGENE LIMITED — Capital/Financing Update 2023

Aug 15, 2023

Market Announcement

==> picture [33 x 50] intentionally omitted <==

16 August 2023

==> picture [451 x 5] intentionally omitted <==

Imugene Limited (ASX: IMU) – Trading Halt

Description

The securities of Imugene Limited (‘IMU’) will be placed in trading halt at the request of IMU, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Friday, 18 August 2023 or when the announcement is released to the market.

Issued by

Melissa Kostopoulos

Adviser, Listings Compliance

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

16 August 2023 ASX Limited

==> picture [126 x 50] intentionally omitted <==

Imugene Limited Suite 12.01, Level 12 ABN 99 009 179 551 4-6 Bligh Street www.imugene.com Sydney NSW 2000 AUSTRALIA

16 August 2023

Ms Melissa Kostopoulous Compliance Adviser ASX Limited Level 4, North Tower, Rialto 525 Collins Street Melbourne VIC 3000

Via email: tradinghaltsmelbourne@asx.com.au

Dear Melissa

TRADING HALT REQUEST – ASX: IMU

In accordance with ASX Listing Rule 17.1, Imugene Limited (the Company ) hereby requests that its securities be placed into an immediate trading halt. For the purposes of Listing Rule 17.1, the Company provides the following information:

• (a) The Company is seeking a trading halt pending an announcement in relation to a proposed capital raising;

• (b) the Company requests that the trading halt remain in place until the earlier of the Company releasing an announcement in relation to the capital raising or the opening of trading on Friday, 18 August 2023;

• (c) the Company is not aware of any reason why the trading halt should not be granted; and

• (d) the Company is not aware of any other information necessary to inform the market about the trading halt.

Yours sincerely

==> picture [107 x 46] intentionally omitted <==

Mike Tonroe Company Secretary